Weight loss is a cornerstone of OSA management, and GLP-1 RAs may offer dual benefits in this population by improving both apnea severity and BP control
There are multiple drugs producing clinically relevant weight loss 9 , including semaglutide (S)a long-acting glucagon-like peptide-1 (GLP-1) 10 analogue and cagrilintide (C)a long-acting amylin analogue 11
While currently available GLP-1 RAs must be injected subcutaneously, oral administration may lead to earlier GLP-1 RA treatment initiation, and may improve acceptance and adherence for some patients [3, 4]
If you're working with 100mcg, the 4mL dilution makes it a simple 4-unit draw, which is far more accurate than trying to estimate 1 unit on the 1mL dilution
The federal government approved the use of GLP-1 drugs for children starting at age 12 four years ago, she said
Furthermore, insights into KPV's mechanism of action propose a novel approach to drug delivery, targeting proteins modulated in disease conditions to concentrate drug activity